Search results for "Gallium-68"

showing 8 items of 8 documents

Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of pote…

2019

Abstract Curcumin metal complexes showed widespread applications in medicine and can be exploited as a lead structure for developing new tracers for nuclear medicine application. Herein, the synthesis, chemical characterization and radiolabelling with gallium-68 and scandium-44 of two new targeting vectors based on curcumin scaffolds and linked to the chelators 1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid (NODAGA) and 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)]amino-6-methylperhydro-1,4-diazepine (AAZTA) are reported. Synthesis of the precursors could be achieved with a 13% and 11% yield and radiolabelling generally afforded rapid incorporation under mild conditions (>95%). Sta…

CurcuminRadionuclide imagingGallium RadioisotopesPyrazole010402 general chemistry01 natural sciencesBiochemistryInorganic Chemistrychemistry.chemical_compoundMoietyAnimalsHumansTissue DistributionRadioactive TracersBifunctionalDerivatizationPET radiopharmaceuticalsChelating AgentsRadioisotopes010405 organic chemistryGallium-68Combinatorial chemistryIn vitro0104 chemical scienceschemistryYield (chemistry)Positron-Emission TomographyLipophilicityNuclear medicineCurcuminCurcumin; Gallium-68; Nuclear medicine; PET radiopharmaceuticals; Radionuclide imaging; Scandium-44RadiopharmaceuticalsScandium-44Scandium
researchProduct

68 Ga‐Labelled Tropane Analogues for the Visualization of the Dopaminergic System

2020

Abstract The development of radiometal‐labelled pharmaceuticals for neuroimaging could offer great potential due to easier handling during labelling and availability through radionuclide generator systems. Nonetheless, to date, no such tracers are available for positron emission tomography, primarily owing to the challenge of crossing the blood–brain barrier (BBB) and loss of affinity through chelator attachment. We have prepared a variety of 68Ga‐labelled phenyltropanes showing that, through a simple hydrocarbon‐linker, it is possible to introduce a chelator onto the lead structure while maintaining its high affinity for hDAT (human dopamine transporter) and simultaneously achieving adequa…

Rat modeltropane01 natural sciencesBiochemistrychemistry.chemical_compoundgallium-68Drug DiscoverylipophilicitymedicineGeneral Pharmacology Toxicology and PharmaceuticsradiopharmaceuticalsDopamine transporterPharmacologyFull Paperbiologymedicine.diagnostic_test010405 organic chemistryChemistryOrganic ChemistryDopaminergicdopamine transportersTropaneFull Papers0104 chemical sciencesimaging agents010404 medicinal & biomolecular chemistryPositron emission tomographyLipophilicityLead structurebiology.proteinBiophysicsMolecular MedicineRadionuclide GeneratorChemMedChem
researchProduct

Maturation of a Key Resource – The Germanium-68/Gallium-68 Generator: Development and New Insights

2011

(68)Ge/(68)Ga radionuclide generators have been investigated for almost fifty years, since the cyclotron-independent availability of positron emitting (68)Ga via the (68)Ge/(68)Ga system had always attracted researches working in basic nuclear chemistry as well as radiopharmaceutical chemistry. However, it took decades and generations of research (and researchers) to finally reach a level of (68)Ge/(68)Ga radionuclide generator designs adequate to the modern requirements of radiometal labelling chemistry. Nevertheless, most of the existing commercial generator systems address aspects of (68)Ge breakthrough and safe synthesis of (68)Ga radiopharmaceuticals by adopting eluate post-processing …

chemistry.chemical_elementGallium RadioisotopesGermaniumNanotechnologyChemical FractionationRadiology Nuclear Medicine and imagingCation Exchange ResinsProcess engineeringAnion Exchange ResinsEdetic AcidChelating AgentsRadioisotopesPharmacologyGenerator (computer programming)Gallium-68 generatorGermaniumbusiness.industryRadionuclide GeneratorsSolid Phase ExtractionChemical fractionationRadioactivitychemistryPositron-Emission TomographyRadiopharmaceuticalsRadionuclide GeneratorbusinessCurrent Radiopharmaceuticals
researchProduct

Labeling of DOTA-conjugated HPMA-based polymers with trivalent metallic radionuclides for molecular imaging.

2017

Background In this work, the in vitro and in vivo stabilities and the pharmacology of HPMA-made homopolymers were studied by means of radiometal-labeled derivatives. Aiming to identify the fewer amount and the optimal DOTA-linker structure that provides quantitative labeling yields, diverse DOTA-linker systems were conjugated in different amounts to HPMA homopolymers to coordinate trivalent radiometals Me(III)* = gallium-68, scandium-44, and lutetium-177. Results Short linkers and as low as 1.6% DOTA were enough to obtain labeling yields > 90%. Alkoxy linkers generally exhibited lower labeling yields than alkane analogues despite of similar chain length and DOTA incorporation rate. High sta…

lcsh:Medical physics. Medical radiology. Nuclear medicinelcsh:R895-920Gallium-68610 MedizinDOTA-HPMA conjugatesPETBiodistributionTheranostic610 Medical sciencesScandium-44Lutetium-177neoplasmsOriginal ResearchRadiolabelingEJNMMI research
researchProduct

Design of Bimodal Ligands of Neurotensin Receptor 1 for Positron Emission Tomography Imaging and Fluorescence-Guided Surgery of Pancreatic Cancer

2020

International audience; Neurotensin receptor 1 (NTSR1) is overexpressed in most human pancreatic ductal adenocarcinomas. It makes it an attractive target for the development of pancreatic cancer imaging agents. In this study, we sought to develop a bimodal PET-fluorescent imaging agent capable of specifically targeting these receptors. Starting from the structure of a known NTSR1 agonist, a series of tracers was synthesized, radiometalated with gallium-68 and evaluated in vitro and in vivo, in mice bearing an AsPC-1 xenograft. PET imaging allowed us to identify the compound [ 68 Ga]Ga-NODAGA-Lys(Cy5**)-AEEAc-[Me-Arg 8 , Tle 12 ]-NT(7-13) as the one with the most promising biodistribution pr…

Neurotensin receptor 1positron emission tomographydual-modality[SDV]Life Sciences [q-bio]Gallium RadioisotopesAcetatesLigands01 natural sciencesHeterocyclic Compounds 1-RingMice03 medical and health sciencesgallium-68Cell Line TumorPancreatic cancerDrug DiscoverymedicineAnimalsHumansReceptors Neurotensin[CHIM]Chemical SciencesPancreatic carcinomaPancreasNeurotensinFluorescent Dyes030304 developmental biology0303 health sciencesmedicine.diagnostic_testChemistryOptical Imagingmedicine.diseaseFluorescence0104 chemical sciencesPancreatic Neoplasms010404 medicinal & biomolecular chemistrySurgery Computer-AssistedPositron emission tomographyPositron-Emission TomographyCancer researchMolecular MedicineFemalefluorescence-guided surgery
researchProduct

Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC

2019

Purpose The widespread use of 68Ga for positron emission tomography (PET) relies on the development of radiopharmaceutical precursors that can be radiolabelled and dispensed in a simple, quick, and convenient manner. The DATA (6-amino-1,4-diazapine-triacetate) scaffold represents a novel hybrid chelator architecture possessing both cyclic and acyclic character that may allow for facile access to 68Ga-labelled tracers in the clinic. We report the first bifunctional DATA chelator conjugated to [Tyr3]octreotide (TOC), a somatostatin subtype 2 receptor (SST2)-targeting vector for imaging and functional characterisation of SSTR2 expressing tumours. Methods The radiopharmaceutical precursor, DATA…

lcsh:Medical physics. Medical radiology. Nuclear medicineNET540 Chemistry and allied sciencesDOTA-TOC540 Chemielcsh:R895-920Gallium-68PET-CTDATA-TOCMolecular imagingOriginal ResearchSomatostatin receptorEJNMMI Research
researchProduct

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators

2020

Abstract Background Fibroblast activation protein (FAP) is a proline selective serine protease that is overexpressed in tumor stroma and in lesions of many other diseases that are characterized by tissue remodeling. In 2014, a most potent FAP-inhibitor (referred to as UAMC1110) with low nanomolar FAP-affinity and high selectivity toward related enzymes such as prolyl oligopeptidase (PREP) and the dipeptidyl-peptidases (DPPs): DPP4, DPP8/9 and DPP2 were developed. This inhibitor has been adopted recently by other groups to create radiopharmaceuticals by coupling bifunctional chelator-linker systems. Here, we report squaric acid containing bifunctional DATA5m and DOTA chelators relied on UAMC…

Computer. Automationlcsh:Medical physics. Medical radiology. Nuclear medicine540 Chemistry and allied sciencesPREPPharmacology. Therapylcsh:R895-920Gallium-68lcsh:RM1-950610 MedizinFAPDATA5mChemistrylcsh:Therapeutics. PharmacologyDOTA540 Chemie610 Medical sciencesSquaric acidneoplasmsEJNMMI Radiopharmacy and Chemistry
researchProduct

Approaching ‘kit-type’ labelling with 68Ga : the DATA chelators.

2015

The DATA chelators are a novel class of tri-anionic ligands based on 6-amino-1,4-diazepine-triacetic acid, which have been introduced recently for the chelation of (68)Ga. Compared with macrocyclic chelators based on the cyclen scaffold (i.e., DOTA, DO3A, and DO2A derivatives), DATA chelators undergo quantitative radiolabelling more rapidly and under milder conditions. In this study, a systematic evaluation of the labelling of four DATA chelators--DATA(M), DATA(P), DATA(Ph), and DATA(PPh)--with (68)Ga is presented. The results highlight the extraordinary potential of this new class of chelators for application in molecular imaging using (68)Ga positron emission tomography (PET).

PharmacologyStereochemistryRadiopharmaceuticals.Organic ChemistryGallium-68Gallium RadioisotopesBiochemistryLigand designchemistry.chemical_compoundKineticsMacrocyclic ligandsCyclenchemistryLabellingIsotope LabelingDrug DiscoveryChelatesMolecular MedicineDOTAChelationGeneral Pharmacology Toxicology and PharmaceuticsMolecular imagingChelating Agents
researchProduct